LY404187
CAS No. 211311-95-4
LY404187( —— )
Catalog No. M21047 CAS No. 211311-95-4
LY404187 is a positive allosteric modulator of AMPA receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | Get Quote |
|
| 10MG | 125 | Get Quote |
|
| 25MG | 250 | Get Quote |
|
| 50MG | 376 | Get Quote |
|
| 100MG | 536 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLY404187
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY404187 is a positive allosteric modulator of AMPA receptors.
-
DescriptionLY404187 is a positive allosteric modulator of AMPA receptors.
-
In VitroLY-404187 (3-10 nM) potentiates glutamate-evoked inward currents in human GluR4 transfected HEK293 cells.LY-404187 (0.03-10 μM) selectively enhances glutamate-evoked currents through AMPA receptor/channels of acutely isolated pyramidal neurons with considerably greater potency (EC50=1.3±0.3 μM) and efficacy (Emax=45.3±8.0-fold increase) .LY-404187 does not affect the magnitude or time course of wholecell K+ or Na+ currents in pre frontal cortex (PFC) pyramidal neurons at concentrations of 10 μM.
-
In VivoLY-404187 (0.5 mg/kg; s.c for 11 days) can prevent MPTP-induced neurotoxicity in mice.LY-404187 (0.5 mg/kg; s.c. for 28 days) attenuates apomorphine-induced contraversive rotations and affords significant protection against the loss of tyrosine hydroxylase positive nigral cell bodies.LY-404187 (0.1 or 0.5 mg/kg; s.c. for 14 days) affords functional, neurochemical and histological protection after infusion of 6-hydroxydopamine into the substantia nigra in rats.LY-404187 (0.5 mg/kg; s.c. for 14 days) delayed treatment provides functional and histological improvement, suggesting a trophic action as administration is initiated after cell death.LY-404187 (0.1 and 0.5 mg/kg; s.c. for 14 days) increases GAP-43 immunoreactivity in the striatum in a dose-dependent manner. Animal Model:Male C57BL/6J mice (20-25 g) are challenged with MPTP on day 8 Dosage:0.5 mg/kg Administration:S.c; twice daily on weekdays and once daily at weekends for 11 days Result:Attenuated the loss of tyrosine hydroxylase immunoreactivity in the substantia nigra.No significant change in tyrosine hydroxylase immunoreactivity in the dorsal and ventral striatum.
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorAMPA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number211311-95-4
-
Formula Weight342.46
-
Molecular FormulaC19H22N2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (292.00 mM)
-
SMILESCC(CNS(=O)(=O)C(C)C)c1ccc(-c2ccc(C#N)cc2)cc1
-
Chemical Name2-Propanesulfonamide N-(2-(4'-cyano(11'-biphenyl)-4-yl)propyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Quirk J C Nisenbaum E S . LY404187: A novel positive allosteric modulator of AMPA receptors[J]. Cns Drug Reviews 2002 8(3):255-282.
molnova catalog
related products
-
GLPG0634 analogue
GLPG0634 (analog) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively.
-
ML289
ML289 (VU0463597) is a potent, selective, and CNS-penetrant negative allosteric modulator of mGlu3 (IC50=0.66 μM), with over 15-fold selectivity compared to mGlu2 and no activity against mGlu5.
-
LY2608204
LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Cart
sales@molnova.com